Market Cap 1.25B
Revenue (ttm) 348.97M
Net Income (ttm) 5.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 1.68%
Debt to Equity Ratio -6.28
Volume 3,291,236
Avg Vol 4,945,086
Day's Range N/A - N/A
Shares Out 321.54M
Stochastic %K 85%
Beta 1.12
Analysts Strong Sell
Price Target $7.97

Company Profile

MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. It offers Afrezza inhalation powder, an inhaled insulin used to improve glycemic control in adults with diabetes; and the V-Go wearable insulin delivery device, which provi...

Industry: Biotechnology
Sector: Healthcare
Phone: 818 661 5000
Address:
1 Casper Street, Danbury, United States
clan
clan Aug. 19 at 7:03 PM
$MNKD @pierrules ↗️↗
0 · Reply
KabOOOM
KabOOOM Aug. 19 at 7:01 PM
$MNKD price action this friday will be violent.
1 · Reply
biotech_sellout
biotech_sellout Aug. 19 at 6:54 PM
$MNKD march back to $5 by the end of the month would be nice.
0 · Reply
lsb1201030758
lsb1201030758 Aug. 19 at 6:40 PM
$MNKD It's more fun when it goes up...
2 · Reply
oloccip__evets
oloccip__evets Aug. 19 at 6:37 PM
0 · Reply
Sophia_Petrillo
Sophia_Petrillo Aug. 19 at 6:25 PM
$MNKD or not much volume and just sit there and bounce back-and-forth between $4.35 and $4.36 lol for now
1 · Reply
NatesNotes
NatesNotes Aug. 19 at 6:19 PM
$MNKD ...with a reminder of what they really represent on a longer-term chart! Looking forward to more gains in the months and years ahead as the story continues to unfold! Cheers! #knowwhatyouown #factsmatter
1 · Reply
clan
clan Aug. 19 at 6:18 PM
$MNKD $SPY $QQQ Breakout is next ☕️; for the good of all Mannkind.
0 · Reply
NatesNotes
NatesNotes Aug. 19 at 6:18 PM
$MNKD Watching blue and green on a shorter-term chart (those "amusing" $4.60 and $6.40 levels)...
0 · Reply
Pats6X
Pats6X Aug. 19 at 6:16 PM
$MNKD shhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
0 · Reply
Latest News on MNKD
MannKind price target lowered to $13 from $14 at Wells Fargo

2026-08-06T10:15:53.000Z - 13 days ago

MannKind price target lowered to $13 from $14 at Wells Fargo


MannKind reports Q2 EPS (6c), consensus 2c

2026-08-05T20:37:06.000Z - 13 days ago

MannKind reports Q2 EPS (6c), consensus 2c


MannKind Earnings Call Transcript: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

MannKind Earnings Call Transcript: Q2 2026


MannKind Earnings release: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

MannKind Earnings release: Q2 2026


MannKind Quarterly report: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

MannKind Quarterly report: Q2 2026


MannKind Slides: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

MannKind Slides: Q2 2026


MannKind price target raised to $14 from $11 at Wells Fargo

2026-07-30T10:30:28.000Z - 20 days ago

MannKind price target raised to $14 from $11 at Wells Fargo


MannKind Transcript: Study result

Jul 29, 2026, 4:30 PM EDT - 20 days ago

MannKind Transcript: Study result


MannKind Press release: Study result

Jul 29, 2026, 4:30 PM EDT - 20 days ago

MannKind Press release: Study result


MannKind Slides: Study result

Jul 29, 2026, 4:30 PM EDT - 20 days ago

MannKind Slides: Study result


MannKind reports ‘positive’ Phase 1b INFLO-1 results

2026-07-29T10:45:42.000Z - 21 days ago

MannKind reports ‘positive’ Phase 1b INFLO-1 results


MannKind Transcript: FDA announcement

Jul 24, 2026, 9:00 AM EDT - 26 days ago

MannKind Transcript: FDA announcement


MannKind Press release: FDA announcement

Jul 24, 2026, 9:00 AM EDT - 26 days ago

MannKind Press release: FDA announcement


MannKind Slides: FDA announcement

Jul 24, 2026, 9:00 AM EDT - 26 days ago

MannKind Slides: FDA announcement


MannKind announces FDA approval of Furoscix ReadyFlow

2026-07-24T10:41:33.000Z - 26 days ago

MannKind announces FDA approval of Furoscix ReadyFlow


MannKind announces $50M private placement

2026-07-24T10:40:57.000Z - 26 days ago

MannKind announces $50M private placement


MannKind Announces $50 Million Private Placement

Jul 24, 2026, 6:35 AM EDT - 26 days ago

MannKind Announces $50 Million Private Placement


MannKind price target raised to $11 from $10 at Wells Fargo

2026-06-01T01:10:05.000Z - 2 months ago

MannKind price target raised to $11 from $10 at Wells Fargo


MannKind Transcript: FDA announcement

May 29, 2026, 4:30 PM EDT - 2 months ago

MannKind Transcript: FDA announcement


US FDA approves MannKind's inhaled insulin for children

May 29, 2026, 12:44 PM EDT - 2 months ago

US FDA approves MannKind's inhaled insulin for children


MannKind to Present at Jefferies Global Healthcare Conference

May 27, 2026, 4:00 PM EDT - 2 months ago

MannKind to Present at Jefferies Global Healthcare Conference


MannKind Transcript: AGM 2026

May 20, 2026, 9:00 AM EDT - 3 months ago

MannKind Transcript: AGM 2026


MannKind price target lowered to $7 from $8 at Mizuho

2026-05-07T15:49:43.000Z - 3 months ago

MannKind price target lowered to $7 from $8 at Mizuho


MannKind price target raised to $10 from $8 at H.C. Wainwright

2026-05-07T11:37:11.000Z - 3 months ago

MannKind price target raised to $10 from $8 at H.C. Wainwright


MannKind price target raised to $10 from $8 at Wells Fargo

2026-05-07T10:51:50.000Z - 3 months ago

MannKind price target raised to $10 from $8 at Wells Fargo


MannKind reports Q1 EPS (2c), consensus 1c

2026-05-07T01:17:30.000Z - 3 months ago

MannKind reports Q1 EPS (2c), consensus 1c


MannKind Earnings Call Transcript: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

MannKind Earnings Call Transcript: Q1 2026


MannKind Earnings release: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

MannKind Earnings release: Q1 2026


MannKind Quarterly report: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

MannKind Quarterly report: Q1 2026


MannKind Slides: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

MannKind Slides: Q1 2026


MannKind price target lowered to $8 from $10 at Mizuho

2026-04-13T14:45:40.000Z - 4 months ago

MannKind price target lowered to $8 from $10 at Mizuho


MannKind price target lowered to $6 from $7 at Truist

2026-04-08T12:35:39.000Z - 4 months ago

MannKind price target lowered to $6 from $7 at Truist


MannKind Proxy statement: Proxy filing

Apr 7, 2026, 8:00 AM EDT - 4 months ago

MannKind Proxy statement: Proxy filing


MannKind Proxy statement: Proxy filing

Apr 7, 2026, 8:00 AM EDT - 4 months ago

MannKind Proxy statement: Proxy filing


MannKind Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 3:40 PM EDT - 5 months ago

MannKind Transcript: Leerink Global Healthcare Conference 2026


MannKind Announces Settlement of Convertible Senior Notes

Mar 5, 2026, 4:30 PM EST - 5 months ago

MannKind Announces Settlement of Convertible Senior Notes


MannKind price target lowered to $8 from $10 at Wedbush

2026-03-05T14:03:29.000Z - 5 months ago

MannKind price target lowered to $8 from $10 at Wedbush

UTHR


MannKind to Participate in Upcoming Investor Conferences

Mar 4, 2026, 9:00 AM EST - 6 months ago

MannKind to Participate in Upcoming Investor Conferences


MannKind price target lowered to $7 from $8 at Wells Fargo

2026-02-27T12:57:54.000Z - 6 months ago

MannKind price target lowered to $7 from $8 at Wells Fargo


MannKind Earnings Call Transcript: Q4 2025

Feb 26, 2026, 9:00 AM EST - 6 months ago

MannKind Earnings Call Transcript: Q4 2025


MannKind Annual report: Q4 2025

Feb 26, 2026, 9:00 AM EST - 6 months ago

MannKind Annual report: Q4 2025


MannKind Earnings release: Q4 2025

Feb 26, 2026, 9:00 AM EST - 6 months ago

MannKind Earnings release: Q4 2025


MannKind Slides: Q4 2025

Feb 26, 2026, 9:00 AM EST - 6 months ago

MannKind Slides: Q4 2025


MannKind Slides: Corporate presentation

Jan 10, 2026, 7:00 AM EST - 7 months ago

MannKind Slides: Corporate presentation


MannKind Provides Business Updates and 2026 Growth Drivers

Jan 8, 2026, 8:05 AM EST - 7 months ago

MannKind Provides Business Updates and 2026 Growth Drivers


MannKind Shares FUROSCIX® Business Updates

Dec 23, 2025, 8:05 AM EST - 8 months ago

MannKind Shares FUROSCIX® Business Updates


MannKind Transcript: Jefferies London Healthcare Conference 2025

Nov 19, 2025, 6:30 AM EST - 9 months ago

MannKind Transcript: Jefferies London Healthcare Conference 2025


MannKind to Present at the Jefferies Global Healthcare Conference

Nov 11, 2025, 4:05 PM EST - 10 months ago

MannKind to Present at the Jefferies Global Healthcare Conference


MannKind Transcript: Study Update

Nov 10, 2025, 9:00 AM EST - 10 months ago

MannKind Transcript: Study Update


MannKind Press release: Study Update

Nov 10, 2025, 9:00 AM EST - 10 months ago

MannKind Press release: Study Update


MannKind Earnings Call Transcript: Q3 2025

Nov 5, 2025, 9:00 AM EST - 10 months ago

MannKind Earnings Call Transcript: Q3 2025


MannKind Quarterly report: Q3 2025

Nov 5, 2025, 9:00 AM EST - 10 months ago

MannKind Quarterly report: Q3 2025


MannKind Earnings release: Q3 2025

Nov 5, 2025, 9:00 AM EST - 10 months ago

MannKind Earnings release: Q3 2025


MannKind Slides: Q3 2025

Nov 5, 2025, 9:00 AM EST - 10 months ago

MannKind Slides: Q3 2025


MannKind to Present at Upcoming Investor Conferences

Aug 27, 2025, 4:05 PM EDT - 1 year ago

MannKind to Present at Upcoming Investor Conferences


MannKind Transcript: M&A Announcement

Aug 25, 2025, 8:30 AM EDT - 1 year ago

MannKind Transcript: M&A Announcement


MannKind Press release: M&A Announcement

Aug 25, 2025, 8:30 AM EDT - 1 year ago

MannKind Press release: M&A Announcement


MannKind Earnings Call Transcript: Q2 2025

Aug 6, 2025, 9:00 AM EDT - 1 year ago

MannKind Earnings Call Transcript: Q2 2025


MannKind Quarterly report: Q2 2025

Aug 6, 2025, 9:00 AM EDT - 1 year ago

MannKind Quarterly report: Q2 2025


MannKind Earnings release: Q2 2025

Aug 6, 2025, 9:00 AM EDT - 1 year ago

MannKind Earnings release: Q2 2025


MannKind Slides: Corporate Presentation

Aug 6, 2025, 7:00 AM EDT - 1 year ago

MannKind Slides: Corporate Presentation


MannKind Slides: FY 2025

Jun 5, 2025, 2:35 PM EDT - 1 year ago

MannKind Slides: FY 2025


MannKind Earnings Call Transcript: Q1 2025

May 8, 2025, 9:00 AM EDT - 1 year ago

MannKind Earnings Call Transcript: Q1 2025


MannKind Quarterly report: Q1 2025

May 8, 2025, 9:00 AM EDT - 1 year ago

MannKind Quarterly report: Q1 2025


MannKind Earnings release: Q1 2025

May 8, 2025, 9:00 AM EDT - 1 year ago

MannKind Earnings release: Q1 2025


MannKind Proxy statement: Proxy Filing

Apr 1, 2025, 8:00 AM EDT - 1 year ago

MannKind Proxy statement: Proxy Filing


MannKind Proxy statement: Proxy Filing

Apr 1, 2025, 8:00 AM EDT - 1 year ago

MannKind Proxy statement: Proxy Filing


MannKind Earnings Call Transcript: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

MannKind Earnings Call Transcript: Q4 2024


MannKind Annual report: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

MannKind Annual report: Q4 2024


MannKind Earnings release: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

MannKind Earnings release: Q4 2024


MannKind Slides: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

MannKind Slides: Q4 2024


clan
clan Aug. 19 at 7:03 PM
$MNKD @pierrules ↗️↗
0 · Reply
KabOOOM
KabOOOM Aug. 19 at 7:01 PM
$MNKD price action this friday will be violent.
1 · Reply
biotech_sellout
biotech_sellout Aug. 19 at 6:54 PM
$MNKD march back to $5 by the end of the month would be nice.
0 · Reply
lsb1201030758
lsb1201030758 Aug. 19 at 6:40 PM
$MNKD It's more fun when it goes up...
2 · Reply
oloccip__evets
oloccip__evets Aug. 19 at 6:37 PM
0 · Reply
Sophia_Petrillo
Sophia_Petrillo Aug. 19 at 6:25 PM
$MNKD or not much volume and just sit there and bounce back-and-forth between $4.35 and $4.36 lol for now
1 · Reply
NatesNotes
NatesNotes Aug. 19 at 6:19 PM
$MNKD ...with a reminder of what they really represent on a longer-term chart! Looking forward to more gains in the months and years ahead as the story continues to unfold! Cheers! #knowwhatyouown #factsmatter
1 · Reply
clan
clan Aug. 19 at 6:18 PM
$MNKD $SPY $QQQ Breakout is next ☕️; for the good of all Mannkind.
0 · Reply
NatesNotes
NatesNotes Aug. 19 at 6:18 PM
$MNKD Watching blue and green on a shorter-term chart (those "amusing" $4.60 and $6.40 levels)...
0 · Reply
Pats6X
Pats6X Aug. 19 at 6:16 PM
$MNKD shhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
0 · Reply
lutzbittner
lutzbittner Aug. 19 at 6:10 PM
$MNKD nice
0 · Reply
clan
clan Aug. 19 at 6:06 PM
$MNKD 🤔 Maybe it's time. Nahhhh. Not yet. $AMGN 🇺🇲 💪
0 · Reply
Solicurance
Solicurance Aug. 19 at 6:05 PM
$MNKD wild, still low as F… but I’m liking the green
0 · Reply
Chris9879
Chris9879 Aug. 19 at 6:02 PM
$MNKD amgen could still buy mnkd out very cheap
0 · Reply
AboutTime2022
AboutTime2022 Aug. 19 at 5:55 PM
$MNKD If it takes MC or even an Activist. I’m for whatever can get this stock moving up for once. I’m staying positive.😊🤞🍀🐌🐌🐌🐌🍿🍿
2 · Reply
rooksleanne
rooksleanne Aug. 19 at 5:54 PM
0 · Reply
stevemano
stevemano Aug. 19 at 5:51 PM
$MNKD coming soon. Oppenheimer pricing
0 · Reply
Sophia_Petrillo
Sophia_Petrillo Aug. 19 at 5:50 PM
$MNKD watch 4.35 curious to see if we get some volume up through it
0 · Reply
clan
clan Aug. 19 at 5:50 PM
$MNKD 🤔 $20/share 🤔 All-omnipotent Lasagna.🔮 So it is written, so it shall be done.
0 · Reply
NatesNotes
NatesNotes Aug. 19 at 5:48 PM
$MNKD As we've seen today, there are still a lot of sour grapes floating around given that Mike and his team are finding success despite taking the company in a different direction that the bitter group of friends wanted them to take (and despite all the crow they've eaten so far, it appears they are gonna stick with their false narratives, no matter how good the story gets ;-) ). #vdexandfriends #intheirownwords #alwaysblamesomeoneelse #mikehastwogo #factsmatter
0 · Reply
Chris9879
Chris9879 Aug. 19 at 5:45 PM
$MNKD after 4.35 way open
0 · Reply
Chris9879
Chris9879 Aug. 19 at 5:44 PM
$MNKD i am adding 15k more , hitting ressistance. short squeeze could start anytime now
0 · Reply